Publication: The Launch of the European Patients' Academy on Therapeutic Innovation in the Netherlands
"Patient involvement in medicines R&D is evolving and the demand for qualified patient representatives is growing. Dutch stakeholders confirmed the added value of the patients' academy and expressed their willingness to contribute. Important values and conditions for long term collaboration were formulated".
These are the conclusions of the research article: "The Launch of the European Patients' Academy on Therapeutic Innovation in the Netherlands: A Qualitative Multi-Stakeholder Analysis". To read the entire article, please visit Frontiersin.org.